Your browser doesn't support javascript.
loading
Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein.
Horii, Yuto; Iniwa, Toshiki; Onitsuka, Masayoshi; Tsukimoto, Jun; Tanaka, Yuki; Ike, Hironobu; Fukushi, Yuri; Ando, Haruna; Takeuchi, Yoshie; Nishioka, So-Ichiro; Tsuji, Daisuke; Ikuo, Mariko; Yamazaki, Naoshi; Takiguchi, Yoshiharu; Ishimaru, Naozumi; Itoh, Kohji.
Afiliación
  • Horii Y; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Iniwa T; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Onitsuka M; Division of Bioscience and Biotechnology, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan.
  • Tsukimoto J; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Tanaka Y; Department of Medicinal Biotechnology, Faculty of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Ike H; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Fukushi Y; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Ando H; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Takeuchi Y; Department of Medicinal Biotechnology, Faculty of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Nishioka SI; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Tsuji D; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Ikuo M; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Yamazaki N; Department of Clinical Pharmacology, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Takiguchi Y; Department of Clinical Pharmacology, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Ishimaru N; Department of Oral Molecular Pathology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Itoh K; Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
Mol Ther Methods Clin Dev ; 25: 297-310, 2022 Jun 09.
Article en En | MEDLINE | ID: mdl-35573044
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos